Cosmo Pharmaceuticals S.p.A Stock Swiss Exchange
Stocks
IT0004167463
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - CHF | - |
|
| 06-15 | Cosmo Partner Introduces Winlevi Acne Product in Austria, Germany | MT |
| 06-11 | Cosmo Pharmaceuticals Flags Launch of Acne Treatment in Key Markets Across Europe | MT |
| Market Cap | 1.2B 1.37B 1.1B 1.03B 1.95B 131B 1.98B 13.28B 5.15B 64.2B 5.15B 5.04B 221B | P/E 2026 * |
940x | P/E 2027 * | 25.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.17B 1.34B 1.08B 1B 1.9B 128B 1.93B 12.94B 5.02B 62.58B 5.03B 4.91B 216B | EV / Sales 2026 * |
10.9x | EV / Sales 2027 * | 6.56x |
| Free-Float |
39.91% | Yield 2026 * |
2.87% | Yield 2027 * | 3.04% |
Last Transcript: Cosmo Pharmaceuticals S.p.A
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 2024-05-23 | |
| Director of Finance/CFO | - | 2024-11-10 | |
Paolo Lanzarotti
CTO | Chief Tech/Sci/R&D Officer | 53 | 2008-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mauro Ajani
CHM | Chairman | 71 | 2013-12-31 |
| Director/Board Member | 71 | 2012-03-31 | |
Niall Donnelly
BRD | Director/Board Member | 54 | 2024-05-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.86% | +8.65% | +56.45% | +158.84% | 1,063B | |
| +3.57% | +9.15% | +68.70% | +58.92% | 611B | |
| +3.99% | +11.15% | +37.41% | +93.77% | 444B | |
| -1.20% | -0.96% | +26.12% | +20.22% | 324B | |
| +4.94% | +4.51% | +39.76% | +28.93% | 285B | |
| +2.42% | +2.96% | +30.77% | +42.24% | 283B | |
| +2.47% | +6.56% | -24.26% | -39.60% | 219B | |
| +3.55% | +6.47% | +28.79% | +68.52% | 195B | |
| +4.21% | +4.88% | +17.49% | +70.33% | 156B | |
| Average | +1.27% | +2.83% | +31.25% | +55.80% | 397.85B | |
| Weighted average by Cap. | +0.64% | +4.16% | +41.94% | +80.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 107M 123M 98.72M 92.03M 174M 11.72B 178M 1.19B 461M 5.75B 461M 451M 19.79B | 179M 204M 164M 153M 289M 19.48B 295M 1.97B 766M 9.55B 767M 750M 32.89B |
| Net income | 1.46M 1.67M 1.34M 1.25M 2.36M 159M 2.41M 16.12M 6.25M 77.95M 6.26M 6.12M 269M | 50.02M 57.18M 45.95M 42.84M 81.08M 5.46B 82.63M 553M 215M 2.67B 215M 210M 9.21B |
| Net Debt | -30.2M -34.52M -27.74M -25.86M -48.95M -3.29B -49.88M -334M -130M -1.61B -130M -127M -5.56B | -28.83M -32.96M -26.48M -24.69M -46.73M -3.14B -47.62M -319M -124M -1.54B -124M -121M -5.31B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
